In the neuromuscular system, autoimmune antibodies to the nAChR lead to myasthenia gravis [5], and genetic mutations in the nAChR cause congenital myasthenic syndrome (CMS) [6], both of which are characterized by impaired synaptic transmission and muscle weakness. This evidence concerns the gene CHRNA4 and congenital myasthenic syndrome.